Furthermore, patients with lymph node metastasis, with and without the presence of CTCs, displayed no significant difference in respect to the vascular markers sFlt1, PIGF, VEGF, VEGF-C and VEGF-D. This evidence concerns the gene VEGFC and metastatic malignant neoplasm in the lymph nodes.